Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $117
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Hold rating on Zimmer Biomet Holdings (NYSE:ZBH) while raising the price target from $112 to $117.
November 01, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has maintained a Hold rating on Zimmer Biomet Holdings and increased the price target from $112 to $117, indicating a positive outlook.
The increase in the price target from $112 to $117 suggests a positive outlook for Zimmer Biomet Holdings. Although the Hold rating remains unchanged, the raised target indicates that the analyst sees potential for growth, which could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100